Pharming Group N.V.PHARNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank49
3Y CAGR-21.7%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-21.7%/yr
vs +296.1%/yr prior
Acceleration
-317.8pp
Decelerating
Percentile
P49
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 7.08% |
| Q2 2025 | 19.04% |
| Q1 2025 | -12.04% |
| Q4 2024 | 18.27% |
| Q3 2024 | 3.02% |
| Q2 2024 | 39.91% |
| Q1 2024 | -36.30% |
| Q4 2023 | 26.96% |
| Q3 2023 | 18.70% |
| Q2 2023 | 27.83% |
| Q1 2023 | -14.81% |
| Q4 2022 | -14.68% |
| Q3 2022 | 14.75% |
| Q2 2022 | 10.49% |
| Q1 2022 | 2.16% |
| Q4 2021 | 0.00% |
| Q2 2021 | -0.34% |
| Q1 2021 | -37.69% |
| Q4 2020 | 18.69% |
| Q3 2020 | 30.48% |
| Q2 2020 | -17.13% |
| Q1 2020 | 0.35% |
| Q4 2019 | 17.69% |
| Q3 2019 | -3.94% |
| Q2 2019 | 27.53% |
| Q1 2019 | 0.17% |
| Q4 2018 | -12.07% |
| Q3 2018 | 37.54% |
| Q2 2018 | -8.38% |
| Q1 2018 | -14.51% |
| Q4 2017 | 33.44% |
| Q3 2017 | 63.54% |
| Q2 2017 | 9.91% |
| Q1 2017 | 160.58% |
| Q4 2016 | 126.95% |
| Q3 2016 | 32.80% |
| Q2 2016 | 6.13% |
| Q1 2016 | 41.91% |
| Q4 2015 | -41.13% |
| Q3 2015 | -11.70% |